Long-term effects of bone marrow-derived cells transplantation in patients with acute myocardial infarction: A meta-analysis

Chinese Medical Journal

Volumn 126, Issue 2, 2013, Pages 353-360

  Chen, Long ^a   Tong, Jia Yi ^a   Jin, Hui ^a   Ren, Xiao Mei ^a   Jin, Hong ^a   Wang, Qing Jie ^a   Ma, Gen Shan ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Bone marrow derived cells; Left ventricular function; Meta analysis; Myocardial infarction

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; BONE MARROW CELL; CELL THERAPY; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; TRANSPLANTATION;

ACUTE DISEASE; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VENTRICULAR FUNCTION, LEFT;

EID: 84872696521     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20121532     Document Type: Article

References (35)

1. Minicucci MF, Azevedo PS, Polegato BF, Paiva SAR, Zornoff LAM. Heart failure after myocardial infarction: clinical implications and treatment. Clin Cardiol 2011; 34: 410-414.
2. Laflamme MA, Murry CE. Heart regeneration. Nature 2011; 473: 326-335.
3. Templin C, Lüscher TF, Landmesser U. Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy: current status and future developments. Int J Dev Biol 2011; 5: 407-417.
4. Shah VK, Shalia KK. Stem cell therapy in acute myocardial infarction: a pot of gold or Pandora's box. Stem Cells Int 2011; Article ID 536758.
5. Tongers J, Losordo DW, Landmesser U. Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur Heart J 2011; 32: 1197-1206.
6. Astori G, Soncin S, Lo Cicero V, Siclari F, Sürder D, Turchetto L, et al. Bone marrow derived stem cells in regenerative medicine as advanced therapy medicinal products. Am J Transl Res 2010; 2: 285-295.
7. Hosoda T, Kajstura J, Leri A, Anversa P. Mechanisms of myocardial regeneration. Circ J 2010; 74: 13-17.
8. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Döbert N, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-3017.
9. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106: 1913-1918.
10. Chen SL, Fang WW, Qian J, Ye F, Liu YH, Shan SJ, et al. Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Chin Med J 2004; 117: 1443-1448.
11. Ruan W, Pan CZ, Huang GQ, Li YL, Ge JB, Shu XH, et al. Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging. Chin Med J 2005; 118: 1175-1181.
12. Assmus B, Rolf A, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, et al; REPAIR-AMI Investigators. Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail 2010; 3: 89-96.
13. Beitnes JO, Hopp E, Lunde K, Solheim S, Arnesen H, Brinchmann JE, et al. Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study. Heart 2009; 95: 1983-1989.
14. Cao F, Sun D, Li C, Narsinh K, Zhao L, LI X, et al. Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up. Eur Heart J 2009; 30: 1986-1994.
15. Malagolil A, Piepoli MF, Armentano C, Vallisa D, Arbasi MC, Rossi A, et al. Bone marrow cell transplantation in patients after acute myocardial infarction and left ventricular dysfunction: long term effects on heart function and remodeling. Eur J Heart Fail Suppl 2010; 9: S97-98.
16. Meyer GP, Wollert KC, Lotz J, Pirr J, Rager U, Lippolt P, et al. Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur Heart J 2009; 30: 2978-2984.
17. Plewka M, Krzemińska-Pakuła M, Peruga JZ, Lipiec P, Kurpesa M, Wierzbowska-Drabik K, et al. The effects of intracoronary delivery of mononuclear bone marrow cells in patients with myocardial infarction: a two year follow-up results. Kardiol Pol 2011; 69: 1234-1240.
18. Beitnes JO, Gjesdal O, Lunde K, Solheim S, Edvardsen T, Arnesen H, et al. Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study. Eur J Echocardiogr 2011; 12: 98-106.
19. Traverse JH, McKenna DH, Harvey K, Jorgenso BC, Olson RE, Bostrom N, et al. Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction. Am Heart J 2010; 160: 428-434.
20. Grajek S, Popiel M, Gil L, Breborowicz P, Lesiak M, Czepczyński R, et al. Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation. Eur Heart J 2010; 31: 691-702.
21. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 2008; 29: 1807-1818.
22. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 989-997.
23. Hristov M, Heussen N, Schober A, Weber C. Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis. J Cell Mol Med 2006; 10: 727-733.
24. Sun L, Zhang T, Lan X, Du G. Effects of stem cell therapy on left ventricular remodeling after acute myocardial infarction: a meta-analysis. Clin Cardiol 2010; 33: 296-302.
25. Takagi H, Umemoto T. Intracoronary stem cell injection improves left ventricular remodeling after acute myocardial infarction: an updated meta-analysis of randomized trials. Int J Cardiol 2011; 151: 226-228.
26. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
27. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (Bone marrow transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006; 113: 1287-1294.
28. Jiang YB, Zhang XL, Tang YL, Ma GS, Shen CX, Wei Q, et al. Effects of heme oxygenase-1 gene modulated mesenchymal stem cells on vasculogenesis in ischemic swine hearts. Chin Med J 2011; 124: 401-407.
29. Yu YS, Shen ZY, Ye WX, Huang HY, Hua F, Chen YH, et al. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium. Chin Med J 2010; 123: 1702-1708.
30. Lovell MJ, Mathur A. Cardiac stem cell therapy: progress from the bench to bedside. Heart 2010; 96: 1531-1537.
31. Malliaras K, Marbán E. Cardiac cell therapy: where we've been, where we are, and where we should be headed. Br Med Bull 2011; 98: 161-185.
32. Jiang Y, Chen L, Tang Y, Ma G, Shen C, Qi C, et al. HO-1 gene overexpression enhances the beneficial effects of superparamagnetic iron oxide labeled bone marrow stromal cells transplantation in swine hearts underwent ischemia/reperfusion: an MRI study. Basic Res Cardiol 2010; 105: 431-442.
33. Macia E, Boyden PA. Stem cell therapy is proarrhythmic. Circulation 2009; 119: 1814-1823.
34. Ter Horst KW. Stem cell therapy for myocardial infarction: are we missing time? Cardiology 2010; 117: 1-10.
35. Singh S, Arora R, Handa K, Khraisat A, Nagajothi N, Molnar J, et al. Stem cells improve left ventricular function in acute myocardial infarction. Clin Cardiol 2009; 32: 176-180.